Hot Pursuit     16-Feb-23
Alembic Pharma gains as Karkhadi facility gets EIR from USFDA
Alembic Pharmaceuticals rose 1.02% to Rs 507.05 after the pharma company received an Establishment Inspection Report (EIR) from the US drug regulator for the inspection carried out at its injectable facility at Karkhadi.
The US Food and Drug Administration (USFDA) conducted the pre-approval inspection from 18 August 2022 to 30 August 2022, for ANDAs filed by the company.

The company said that it has already started receiving ANDA approvals manufactured at Karkhadi facility.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. The company manufactures and markets generic pharmaceutical products all over the world.

The drug maker reported 29% drop in consolidated net profit to Rs 121.92 crore despite a 18.7% rise in net sales to Rs 1509.02 crore in Q3 FY23 over Q3 FY22.

Previous News
  Alembic Pharmaceuticals Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Aug-24   15:00 )
  Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
 ( Hot Pursuit - 08-Mar-23   09:19 )
  Alembic Pharmaceuticals appoints Head - Technical Operations (Sterile & Oncology)
 ( Corporate News - 16-Sep-24   17:45 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 24-Apr-23   17:42 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 24-Apr-23   14:30 )
  Alembic Pharmaceuticals receives USFDA approval for Prazosin Hydrochloride Capsules
 ( Corporate News - 08-Mar-23   09:14 )
  Alembic Pharmaceuticals consolidated net profit declines 18.68% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   14:55 )
  Alembic Pharmaceuticals receives USFDA approval (final & tentative) for 11 products
 ( Corporate News - 03-Jul-24   15:42 )
  Alembic Pharmaceuticals consolidated net profit declines 29.03% in the December 2022 quarter
 ( Results - Announcements 01-Feb-23   17:10 )
  Alembic Pharmaceuticals receives EIR for its Injectable Facility at Karkhadi
 ( Corporate News - 16-Feb-23   15:25 )
  Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
 ( Corporate News - 01-Dec-22   11:17 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top